Regulatoriskt pressmeddelande07.10.2024 klo 02.01Circa Group AS - Decision to file petition for bankruptcy
Regulatoriskt pressmeddelande12.09.2024 klo 19.15CIRCA: Circa Group and Leggera Technologies International Enter into a Supply Agreement for 100% Bio-Derived Bicycle Maintenance Products
Regulatoriskt pressmeddelande30.08.2024 klo 15.00CIRCA: Circa Group enters into collaboration agreement with Vertec Biosolvent to develop market for CyreneTM in the Americas
Regulatoriskt pressmeddelande22.08.2024 klo 08.00CIRCA: Q2 2024 Results highlights continued progress on ResoluteTM but solution on funding is still pending
Regulatoriskt pressmeddelande09.08.2024 klo 16.50CIRCA: TRANSFER OF SHARES HELD BY CIRCA GROUP AS ON BEHALF OF SHAREHOLDERS
Regulatoriskt pressmeddelande21.07.2024 klo 19.15Circa Group AS - Increase of required capital to finance Circa activities up to end 2026
Regulatoriskt pressmeddelande15.05.2024 klo 08.00CIRCA: Q1 2024 Results highlight continued progress on ReSoluteTM preparations and a new CEO
Regulatoriskt pressmeddelande03.05.2024 klo 08.00CIRCA: Circa and Ixom partner to develop the market for CyreneTM in Australia and New Zealand
Regulatoriskt pressmeddelande30.04.2024 klo 09.08CIRCA: Circa Group AS announces update on financing and key financial Q1 figures
Regulatoriskt pressmeddelande24.04.2024 klo 17.39CIRCA: Circa and Merck sign OEM agreement for supply and sale of CyreneTM